| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $41.1M | +5.0% |
| SG&A Expense | $18.0M | -16.6% |
| Operating Income | -$59.1M | +2.6% |
| Pre-tax Income | -$57.6M | +5.1% |
| Net Income | -$57.6M | +5.2% |
| EPS (Basic) | -$1.04 | +5.5% |
| EPS (Diluted) | -$1.04 | +5.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.9M | -73.4% |
| Short-term Investments | $58.5M | — |
| Current Assets | $99.1M | -31.2% |
| Total Assets | $115.9M | -29.0% |
| Current Liabilities | $11.1M | +28.1% |
| Total Liabilities | $21.6M | +6.0% |
| Stockholders' Equity | $94.3M | -34.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.6M | +4.1% |
| Capital Expenditures | $1.1M | -66.0% |
| Investing Cash Flow | -$59.1M | -1712.3% |
| Financing Cash Flow | $161K | -78.0% |
| Free Cash Flow | -$46.7M | +8.1% |